Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for ZNF263
Z-value: 2.84
Motif logo
Transcription factors associated with ZNF263
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF263
|
ENSG00000006194.6 | zinc finger protein 263 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF263 | hg19_v2_chr16_+_3333443_3333545 | -0.64 | 2.6e-03 | Click! |
Activity profile of ZNF263 motif
Sorted Z-values of ZNF263 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51504852 | 18.88 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr5_+_137801160 | 14.53 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
| chr1_+_209859510 | 11.69 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr22_-_37640277 | 11.52 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr19_-_51487071 | 10.69 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr22_-_37640456 | 10.56 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr4_-_102268708 | 10.40 |
ENST00000525819.1
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr19_-_12912601 | 9.81 |
ENST00000334482.5
|
PRDX2
|
peroxiredoxin 2 |
| chr8_-_49834299 | 8.77 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
| chr1_-_153588765 | 8.76 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
| chr8_-_49833978 | 8.59 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
| chr22_+_17082732 | 8.15 |
ENST00000558085.2
ENST00000592918.1 ENST00000400593.2 ENST00000592107.1 ENST00000426585.1 ENST00000591299.1 |
TPTEP1
|
transmembrane phosphatase with tensin homology pseudogene 1 |
| chr1_-_6321035 | 8.11 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr3_-_13921594 | 8.04 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr1_+_150480551 | 7.96 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
| chr19_-_12912657 | 7.92 |
ENST00000301522.2
|
PRDX2
|
peroxiredoxin 2 |
| chr9_-_21975088 | 7.85 |
ENST00000304494.5
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr1_+_150480576 | 7.84 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
| chr1_-_153588334 | 7.79 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
| chr9_-_21974820 | 7.68 |
ENST00000579122.1
ENST00000498124.1 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr12_+_4382917 | 7.52 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
| chr19_-_54984354 | 7.38 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
| chr1_+_205473865 | 7.35 |
ENST00000506215.1
ENST00000419301.1 |
CDK18
|
cyclin-dependent kinase 18 |
| chr3_-_46735155 | 7.30 |
ENST00000318962.4
|
ALS2CL
|
ALS2 C-terminal like |
| chr12_-_15103621 | 6.95 |
ENST00000536592.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr6_+_150464155 | 6.80 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chr12_-_6484376 | 6.48 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr1_+_209848749 | 6.26 |
ENST00000367029.4
|
G0S2
|
G0/G1switch 2 |
| chr12_-_54779511 | 6.17 |
ENST00000551109.1
ENST00000546970.1 |
ZNF385A
|
zinc finger protein 385A |
| chr1_+_35220613 | 6.15 |
ENST00000338513.1
|
GJB5
|
gap junction protein, beta 5, 31.1kDa |
| chr8_+_124194752 | 6.07 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr19_+_55587266 | 6.04 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
| chr19_+_16177826 | 6.02 |
ENST00000589897.1
|
TPM4
|
tropomyosin 4 |
| chr2_+_10091783 | 5.94 |
ENST00000324883.5
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr6_+_36098262 | 5.90 |
ENST00000373761.6
ENST00000373766.5 |
MAPK13
|
mitogen-activated protein kinase 13 |
| chr8_+_124194875 | 5.86 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
| chr8_+_95653302 | 5.82 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr19_-_51456198 | 5.76 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr17_-_5487277 | 5.51 |
ENST00000572272.1
ENST00000354411.3 ENST00000577119.1 |
NLRP1
|
NLR family, pyrin domain containing 1 |
| chr19_-_12912688 | 5.48 |
ENST00000435703.1
|
PRDX2
|
peroxiredoxin 2 |
| chr19_-_10679697 | 5.42 |
ENST00000335766.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| chr22_+_31644388 | 5.40 |
ENST00000333611.4
ENST00000340552.4 |
LIMK2
|
LIM domain kinase 2 |
| chr17_-_39674668 | 5.26 |
ENST00000393981.3
|
KRT15
|
keratin 15 |
| chr9_+_71789133 | 5.23 |
ENST00000348208.4
ENST00000265384.7 |
TJP2
|
tight junction protein 2 |
| chr19_-_49568311 | 5.15 |
ENST00000595857.1
ENST00000451356.2 |
NTF4
|
neurotrophin 4 |
| chr3_+_195447738 | 5.13 |
ENST00000447234.2
ENST00000320736.6 ENST00000436408.1 |
MUC20
|
mucin 20, cell surface associated |
| chr6_+_36097992 | 5.12 |
ENST00000211287.4
|
MAPK13
|
mitogen-activated protein kinase 13 |
| chr6_+_41606176 | 5.11 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
| chr3_+_189507460 | 5.10 |
ENST00000434928.1
|
TP63
|
tumor protein p63 |
| chr9_+_71789081 | 5.02 |
ENST00000377245.4
|
TJP2
|
tight junction protein 2 |
| chr19_-_51472031 | 4.95 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr6_-_31846744 | 4.95 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
| chrX_-_73072534 | 4.94 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
| chr14_-_36989427 | 4.92 |
ENST00000354822.5
|
NKX2-1
|
NK2 homeobox 1 |
| chr18_+_21269404 | 4.84 |
ENST00000313654.9
|
LAMA3
|
laminin, alpha 3 |
| chr13_-_46626847 | 4.81 |
ENST00000242848.4
ENST00000282007.3 |
ZC3H13
|
zinc finger CCCH-type containing 13 |
| chr18_+_61420169 | 4.81 |
ENST00000425392.1
ENST00000336429.2 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
| chr1_+_26503894 | 4.74 |
ENST00000361530.6
ENST00000374253.5 |
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1 |
| chr3_+_189507523 | 4.63 |
ENST00000437221.1
ENST00000392463.2 ENST00000392461.3 ENST00000449992.1 ENST00000456148.1 |
TP63
|
tumor protein p63 |
| chr15_-_74726283 | 4.55 |
ENST00000543145.2
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
| chr1_+_205473720 | 4.52 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
| chr14_-_36988882 | 4.52 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
| chr18_+_21269556 | 4.51 |
ENST00000399516.3
|
LAMA3
|
laminin, alpha 3 |
| chr19_-_51466681 | 4.49 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr22_+_31644309 | 4.48 |
ENST00000425203.1
|
LIMK2
|
LIM domain kinase 2 |
| chr6_+_30848771 | 4.45 |
ENST00000503180.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr6_+_7541845 | 4.40 |
ENST00000418664.2
|
DSP
|
desmoplakin |
| chr19_-_10679644 | 4.39 |
ENST00000393599.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| chr6_+_30848740 | 4.37 |
ENST00000505534.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr12_-_54785074 | 4.34 |
ENST00000338010.5
ENST00000550774.1 |
ZNF385A
|
zinc finger protein 385A |
| chr6_-_30654977 | 4.31 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr1_+_205473784 | 4.30 |
ENST00000478560.1
ENST00000443813.2 |
CDK18
|
cyclin-dependent kinase 18 |
| chr1_-_26680570 | 4.28 |
ENST00000475866.2
|
AIM1L
|
absent in melanoma 1-like |
| chr19_-_49258606 | 4.27 |
ENST00000310160.3
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) |
| chr14_-_23834411 | 4.24 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
| chr9_+_130911770 | 4.23 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
| chr1_-_23694794 | 4.22 |
ENST00000374608.3
|
ZNF436
|
zinc finger protein 436 |
| chr5_+_31193847 | 4.21 |
ENST00000514738.1
ENST00000265071.2 |
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney) |
| chr8_+_95653427 | 4.18 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr1_-_159915386 | 4.18 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
| chr8_+_95653373 | 4.17 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr6_+_30848829 | 4.16 |
ENST00000508317.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr2_-_45236540 | 4.15 |
ENST00000303077.6
|
SIX2
|
SIX homeobox 2 |
| chr12_-_54785054 | 4.14 |
ENST00000352268.6
ENST00000549962.1 |
ZNF385A
|
zinc finger protein 385A |
| chr18_+_33877654 | 4.14 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr14_+_75746340 | 4.12 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr1_-_32169920 | 4.11 |
ENST00000373672.3
ENST00000373668.3 |
COL16A1
|
collagen, type XVI, alpha 1 |
| chr4_-_77819002 | 4.11 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr14_+_95078714 | 3.99 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
| chr1_+_158979792 | 3.98 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
| chr4_-_151936416 | 3.96 |
ENST00000510413.1
ENST00000507224.1 |
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing |
| chr7_-_121036337 | 3.95 |
ENST00000426156.1
ENST00000359943.3 ENST00000412653.1 |
FAM3C
|
family with sequence similarity 3, member C |
| chr9_+_109625378 | 3.93 |
ENST00000277225.5
ENST00000457913.1 ENST00000472574.1 |
ZNF462
|
zinc finger protein 462 |
| chr20_-_1306351 | 3.93 |
ENST00000381812.1
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
| chr6_-_32145861 | 3.88 |
ENST00000336984.6
|
AGPAT1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 |
| chr11_-_64612041 | 3.87 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
| chr2_-_241831424 | 3.86 |
ENST00000402775.2
ENST00000307486.8 |
C2orf54
|
chromosome 2 open reading frame 54 |
| chr12_-_6484715 | 3.84 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr20_-_1306391 | 3.83 |
ENST00000339987.3
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
| chr3_+_189507432 | 3.77 |
ENST00000354600.5
|
TP63
|
tumor protein p63 |
| chr4_-_90759440 | 3.75 |
ENST00000336904.3
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr19_+_11200038 | 3.73 |
ENST00000558518.1
ENST00000557933.1 ENST00000455727.2 ENST00000535915.1 ENST00000545707.1 ENST00000558013.1 |
LDLR
|
low density lipoprotein receptor |
| chr22_+_38035623 | 3.72 |
ENST00000336738.5
ENST00000442465.2 |
SH3BP1
|
SH3-domain binding protein 1 |
| chr12_-_54813229 | 3.68 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr2_+_169923504 | 3.67 |
ENST00000357546.2
|
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
| chr11_-_94964210 | 3.66 |
ENST00000416495.2
ENST00000393234.1 |
SESN3
|
sestrin 3 |
| chr6_-_80657292 | 3.65 |
ENST00000369816.4
|
ELOVL4
|
ELOVL fatty acid elongase 4 |
| chr22_+_38035459 | 3.62 |
ENST00000357436.4
|
SH3BP1
|
SH3-domain binding protein 1 |
| chr1_+_158979686 | 3.59 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
| chr1_+_151483855 | 3.56 |
ENST00000427934.2
ENST00000271636.7 |
CGN
|
cingulin |
| chr3_-_46735132 | 3.55 |
ENST00000415953.1
|
ALS2CL
|
ALS2 C-terminal like |
| chr6_+_43044003 | 3.55 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
| chr6_+_30848557 | 3.53 |
ENST00000460944.2
ENST00000324771.8 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr1_+_158979680 | 3.53 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
| chr6_+_36098363 | 3.52 |
ENST00000373759.1
|
MAPK13
|
mitogen-activated protein kinase 13 |
| chr17_-_6616678 | 3.51 |
ENST00000381074.4
ENST00000293800.6 ENST00000572352.1 ENST00000576323.1 ENST00000573648.1 |
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
| chr4_-_80993717 | 3.49 |
ENST00000307333.7
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr9_-_122131696 | 3.48 |
ENST00000373964.2
ENST00000265922.3 |
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
| chr9_+_130911723 | 3.41 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
| chr12_-_6483969 | 3.37 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr1_+_17531614 | 3.35 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
| chr19_+_10736183 | 3.30 |
ENST00000590857.1
ENST00000588688.1 ENST00000586078.1 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
| chr19_+_39687596 | 3.18 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
| chr5_-_175843569 | 3.14 |
ENST00000310418.4
ENST00000345807.2 |
CLTB
|
clathrin, light chain B |
| chr19_-_49565254 | 3.13 |
ENST00000593537.1
|
NTF4
|
neurotrophin 4 |
| chr10_+_72972281 | 3.09 |
ENST00000335350.6
|
UNC5B
|
unc-5 homolog B (C. elegans) |
| chr11_-_46142505 | 3.05 |
ENST00000524497.1
ENST00000418153.2 |
PHF21A
|
PHD finger protein 21A |
| chr4_+_152330390 | 3.02 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr15_+_94774767 | 3.02 |
ENST00000543482.1
|
MCTP2
|
multiple C2 domains, transmembrane 2 |
| chr6_+_32938665 | 3.02 |
ENST00000374831.4
ENST00000395289.2 |
BRD2
|
bromodomain containing 2 |
| chr4_-_102268628 | 2.99 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr2_+_169923577 | 2.99 |
ENST00000432060.2
|
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
| chr22_+_29876197 | 2.96 |
ENST00000310624.6
|
NEFH
|
neurofilament, heavy polypeptide |
| chr20_-_18038521 | 2.95 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
| chr1_-_32169761 | 2.95 |
ENST00000271069.6
|
COL16A1
|
collagen, type XVI, alpha 1 |
| chr19_-_36001286 | 2.95 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr1_+_211432593 | 2.93 |
ENST00000367006.4
|
RCOR3
|
REST corepressor 3 |
| chr1_-_230561475 | 2.89 |
ENST00000391860.1
|
PGBD5
|
piggyBac transposable element derived 5 |
| chr2_-_27718052 | 2.88 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
| chr11_-_59633951 | 2.88 |
ENST00000257264.3
|
TCN1
|
transcobalamin I (vitamin B12 binding protein, R binder family) |
| chr12_-_95044309 | 2.88 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr3_-_195538760 | 2.86 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
| chr6_-_41130914 | 2.85 |
ENST00000373113.3
ENST00000338469.3 |
TREM2
|
triggering receptor expressed on myeloid cells 2 |
| chr6_+_32938692 | 2.83 |
ENST00000443797.2
|
BRD2
|
bromodomain containing 2 |
| chr5_-_138861926 | 2.82 |
ENST00000510817.1
|
TMEM173
|
transmembrane protein 173 |
| chr14_-_71276211 | 2.82 |
ENST00000381250.4
ENST00000555993.2 |
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9 |
| chr5_-_81046904 | 2.82 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
| chr1_-_226374373 | 2.80 |
ENST00000366812.5
|
ACBD3
|
acyl-CoA binding domain containing 3 |
| chrX_-_41782592 | 2.79 |
ENST00000378158.1
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
| chrX_+_73641286 | 2.78 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
| chr5_+_145826867 | 2.77 |
ENST00000296702.5
ENST00000394421.2 |
TCERG1
|
transcription elongation regulator 1 |
| chr6_+_18155560 | 2.75 |
ENST00000546309.2
ENST00000388870.2 ENST00000397244.1 |
KDM1B
|
lysine (K)-specific demethylase 1B |
| chr17_+_7461580 | 2.75 |
ENST00000483039.1
ENST00000396542.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr16_+_57662138 | 2.74 |
ENST00000562414.1
ENST00000561969.1 ENST00000562631.1 ENST00000563445.1 ENST00000565338.1 ENST00000567702.1 |
GPR56
|
G protein-coupled receptor 56 |
| chr11_-_6341844 | 2.74 |
ENST00000303927.3
|
PRKCDBP
|
protein kinase C, delta binding protein |
| chr7_-_139876812 | 2.72 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr1_+_60280458 | 2.68 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr21_-_40720974 | 2.68 |
ENST00000380748.1
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr18_-_47721447 | 2.67 |
ENST00000285039.7
|
MYO5B
|
myosin VB |
| chr6_-_13487784 | 2.65 |
ENST00000379287.3
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
| chr2_-_232328867 | 2.63 |
ENST00000453992.1
ENST00000417652.1 ENST00000454824.1 |
NCL
|
nucleolin |
| chr8_-_144923112 | 2.63 |
ENST00000442628.2
|
NRBP2
|
nuclear receptor binding protein 2 |
| chr5_+_156887027 | 2.63 |
ENST00000435489.2
ENST00000311946.7 |
NIPAL4
|
NIPA-like domain containing 4 |
| chr6_-_10415470 | 2.63 |
ENST00000379604.2
ENST00000379613.3 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr11_-_94965667 | 2.62 |
ENST00000542176.1
ENST00000278499.2 |
SESN3
|
sestrin 3 |
| chr1_-_153321301 | 2.61 |
ENST00000368739.3
|
PGLYRP4
|
peptidoglycan recognition protein 4 |
| chr16_-_28550320 | 2.60 |
ENST00000395641.2
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
| chr3_+_133292851 | 2.58 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
| chr6_+_7541808 | 2.57 |
ENST00000379802.3
|
DSP
|
desmoplakin |
| chr21_-_40720995 | 2.54 |
ENST00000380749.5
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr15_+_74218787 | 2.53 |
ENST00000261921.7
|
LOXL1
|
lysyl oxidase-like 1 |
| chr14_-_67982146 | 2.52 |
ENST00000557779.1
ENST00000557006.1 |
TMEM229B
|
transmembrane protein 229B |
| chr8_-_75233563 | 2.51 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
| chr1_+_211432775 | 2.50 |
ENST00000419091.2
|
RCOR3
|
REST corepressor 3 |
| chr10_+_127585093 | 2.50 |
ENST00000368695.1
ENST00000368693.1 |
FANK1
|
fibronectin type III and ankyrin repeat domains 1 |
| chr17_+_6544078 | 2.50 |
ENST00000250101.5
|
TXNDC17
|
thioredoxin domain containing 17 |
| chr2_-_216300784 | 2.49 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr1_-_225840747 | 2.47 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
| chr1_-_6550625 | 2.47 |
ENST00000377725.1
ENST00000340850.5 |
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr17_-_2206801 | 2.46 |
ENST00000544865.1
|
SMG6
|
SMG6 nonsense mediated mRNA decay factor |
| chr4_-_80994619 | 2.43 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr17_+_8339340 | 2.43 |
ENST00000580012.1
|
NDEL1
|
nudE neurodevelopment protein 1-like 1 |
| chr13_-_52026730 | 2.43 |
ENST00000420668.2
|
INTS6
|
integrator complex subunit 6 |
| chr1_+_28199047 | 2.43 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
| chr12_+_6419877 | 2.42 |
ENST00000536531.1
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
| chr20_-_62168714 | 2.40 |
ENST00000542869.1
|
PTK6
|
protein tyrosine kinase 6 |
| chr11_-_46142615 | 2.40 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr1_+_31883048 | 2.39 |
ENST00000536859.1
|
SERINC2
|
serine incorporator 2 |
| chr1_+_154193325 | 2.38 |
ENST00000428931.1
ENST00000441890.1 ENST00000271877.7 ENST00000412596.1 ENST00000368504.1 ENST00000437652.1 |
UBAP2L
|
ubiquitin associated protein 2-like |
| chr19_+_48216600 | 2.38 |
ENST00000263277.3
ENST00000538399.1 |
EHD2
|
EH-domain containing 2 |
| chr8_+_98656693 | 2.38 |
ENST00000519934.1
|
MTDH
|
metadherin |
| chr20_+_54933971 | 2.36 |
ENST00000371384.3
ENST00000437418.1 |
FAM210B
|
family with sequence similarity 210, member B |
| chr14_+_71374433 | 2.36 |
ENST00000439984.3
|
PCNX
|
pecanex homolog (Drosophila) |
| chr20_+_45523227 | 2.35 |
ENST00000327619.5
ENST00000357410.3 |
EYA2
|
eyes absent homolog 2 (Drosophila) |
| chr4_-_151936865 | 2.34 |
ENST00000535741.1
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing |
| chr1_+_14075865 | 2.34 |
ENST00000413440.1
|
PRDM2
|
PR domain containing 2, with ZNF domain |
| chr12_-_57030096 | 2.33 |
ENST00000549506.1
|
BAZ2A
|
bromodomain adjacent to zinc finger domain, 2A |
| chr1_+_14075903 | 2.33 |
ENST00000343137.4
ENST00000503842.1 ENST00000407521.3 ENST00000505823.1 |
PRDM2
|
PR domain containing 2, with ZNF domain |
| chr5_-_134914673 | 2.32 |
ENST00000512158.1
|
CXCL14
|
chemokine (C-X-C motif) ligand 14 |
| chr6_-_41130841 | 2.32 |
ENST00000373122.4
|
TREM2
|
triggering receptor expressed on myeloid cells 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF263
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.8 | 17.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 4.8 | 14.5 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 3.9 | 15.4 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 3.4 | 13.5 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 2.8 | 8.3 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 2.7 | 16.5 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 2.7 | 18.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 2.7 | 8.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 2.1 | 14.7 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 2.0 | 21.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.8 | 5.5 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.7 | 5.2 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.5 | 18.5 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.5 | 7.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.3 | 1.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 1.2 | 6.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.2 | 3.5 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 1.1 | 4.3 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.0 | 10.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 1.0 | 5.1 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.0 | 3.0 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 1.0 | 6.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 1.0 | 4.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.0 | 3.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 1.0 | 4.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.9 | 3.7 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
| 0.9 | 2.6 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.9 | 16.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.8 | 10.1 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.8 | 3.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.8 | 2.5 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.8 | 4.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.8 | 9.8 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.8 | 3.8 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.8 | 12.9 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.8 | 2.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.8 | 3.8 | GO:0051945 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.7 | 2.1 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.7 | 5.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.7 | 2.1 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.7 | 22.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.7 | 4.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.7 | 6.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.7 | 3.4 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.7 | 2.0 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.6 | 2.5 | GO:0018277 | protein deamination(GO:0018277) |
| 0.6 | 4.4 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.6 | 3.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.6 | 14.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.6 | 16.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.6 | 1.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.6 | 6.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.6 | 3.0 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.6 | 5.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.6 | 1.7 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.6 | 3.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.6 | 1.1 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 | 2.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.5 | 1.1 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.5 | 4.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.5 | 1.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.5 | 3.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.5 | 6.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.5 | 0.5 | GO:0035878 | nail development(GO:0035878) |
| 0.5 | 1.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.5 | 3.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.5 | 6.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.5 | 0.5 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
| 0.5 | 2.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.5 | 7.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 | 2.3 | GO:2000503 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.5 | 4.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.5 | 2.7 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.4 | 11.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.4 | 3.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.4 | 3.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.4 | 0.4 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.4 | 3.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.4 | 0.9 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
| 0.4 | 1.7 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.4 | 2.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.4 | 2.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.4 | 8.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.4 | 2.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 | 7.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.4 | 4.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.4 | 1.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.4 | 2.9 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.4 | 5.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.4 | 5.4 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.4 | 1.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.4 | 2.5 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.4 | 3.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 | 1.0 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.3 | 2.8 | GO:0032439 | endosome localization(GO:0032439) |
| 0.3 | 0.3 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.3 | 0.7 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.3 | 2.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 | 1.0 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 | 1.0 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 | 1.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.3 | 1.0 | GO:0098906 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.3 | 1.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 | 1.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 | 0.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 | 1.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 | 8.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.3 | 11.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 3.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 | 0.9 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.3 | 1.2 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.3 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.3 | 3.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.3 | 1.7 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.3 | 1.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.3 | 3.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.3 | 3.6 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.3 | 1.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 4.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.3 | 1.3 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.3 | 1.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 | 1.6 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090101) |
| 0.3 | 3.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 | 1.8 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.3 | 0.8 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.2 | 3.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 1.5 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 3.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.5 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.2 | 1.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 1.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.2 | 1.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.2 | 2.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.2 | 3.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 1.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 1.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.2 | 1.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.2 | 5.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 2.9 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.2 | 2.9 | GO:0015889 | cobalt ion transport(GO:0006824) cobalamin transport(GO:0015889) |
| 0.2 | 0.9 | GO:0048839 | inner ear development(GO:0048839) |
| 0.2 | 1.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.2 | 1.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 3.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 1.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.2 | 0.8 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.2 | 1.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 | 1.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 | 1.2 | GO:0030100 | regulation of endocytosis(GO:0030100) |
| 0.2 | 4.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 4.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 1.0 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 | 3.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.2 | 3.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 | 4.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 2.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.2 | 1.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
| 0.2 | 2.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 2.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.2 | 5.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.2 | 4.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.2 | 0.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.2 | 10.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.2 | 1.9 | GO:0015820 | leucine transport(GO:0015820) |
| 0.2 | 1.3 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 | 0.2 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.2 | 0.8 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 | 4.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 3.9 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.2 | 3.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 2.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.4 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 | 1.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 | 12.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.2 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 0.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 4.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 1.1 | GO:0030047 | actin modification(GO:0030047) |
| 0.2 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 3.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.2 | 0.2 | GO:0033082 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.2 | 1.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 | 4.7 | GO:0033622 | integrin activation(GO:0033622) |
| 0.2 | 3.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.2 | 1.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 1.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.2 | 2.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 2.3 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.2 | 1.4 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.2 | 0.9 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.2 | 1.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 2.6 | GO:0046834 | lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 2.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 | 4.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 2.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.1 | 0.7 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 1.6 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 5.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 | 0.4 | GO:2000981 | auditory receptor cell fate determination(GO:0042668) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.1 | 0.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 | 1.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 1.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) maintenance of DNA repeat elements(GO:0043570) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.5 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 1.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.8 | GO:1901906 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.5 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 | 1.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.1 | 3.9 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 1.6 | GO:0061458 | reproductive system development(GO:0061458) |
| 0.1 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.1 | 1.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.1 | 0.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.1 | 1.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.9 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 2.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.8 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 | 0.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 2.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.1 | 1.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 5.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 1.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 11.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 | 2.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 0.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 1.0 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 1.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.1 | 2.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 4.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 | 1.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 4.4 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.5 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.1 | 3.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 2.0 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.1 | 0.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.1 | 0.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 | 0.6 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 3.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 2.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 1.7 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 3.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 0.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 | 0.3 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.1 | 10.3 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 0.6 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.1 | 1.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.5 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.1 | 1.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 0.4 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.1 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.1 | 0.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 2.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 2.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 5.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 2.0 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 1.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.1 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 1.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 1.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 6.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 0.8 | GO:0070779 | sulfur amino acid transport(GO:0000101) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 2.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.1 | 1.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 5.8 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 1.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 1.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 3.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 8.0 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 3.8 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 1.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 1.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 13.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.9 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
| 0.1 | 1.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 1.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 0.8 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.1 | 0.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 | 1.3 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.1 | 1.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 2.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 1.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 1.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.0 | 2.9 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 0.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.0 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.0 | 0.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.0 | 0.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.0 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 0.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 5.8 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 3.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 3.9 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.0 | 2.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 0.2 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) snRNA import into nucleus(GO:0061015) |
| 0.0 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 | 1.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.5 | GO:0031214 | biomineral tissue development(GO:0031214) |
| 0.0 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 | 0.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.0 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.0 | 0.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 | 0.8 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 | 0.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 4.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.0 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 | 2.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.0 | 1.8 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.0 | 0.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.0 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.0 | 0.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.0 | 1.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.5 | GO:1904353 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
| 0.0 | 0.4 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.0 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 | 0.4 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 1.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.0 | 1.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 1.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.0 | 0.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.0 | 2.8 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.1 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.0 | 0.3 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.0 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 1.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 0.5 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.1 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.0 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.1 | GO:1903280 | regulation of amino acid import(GO:0010958) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 0.0 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 | 1.8 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 | 1.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.0 | 0.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 1.3 | GO:0045453 | bone resorption(GO:0045453) |
| 0.0 | 0.4 | GO:0030220 | platelet formation(GO:0030220) |
| 0.0 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 1.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 | 1.3 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.0 | 1.2 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.0 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 0.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.0 | 0.3 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.0 | 0.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 | 0.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 | 0.6 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 3.0 | GO:0042742 | defense response to bacterium(GO:0042742) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.9 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 | 0.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.4 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.0 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.0 | 1.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.0 | 0.0 | GO:0002545 | microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.0 | 0.8 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
| 0.0 | 0.1 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.0 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 0.4 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 | 0.1 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.2 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 1.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.0 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 16.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 2.2 | 17.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.5 | 15.4 | GO:0005955 | calcineurin complex(GO:0005955) |
| 1.5 | 18.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.1 | 19.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 1.0 | 5.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.9 | 3.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.9 | 2.6 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.8 | 9.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.8 | 5.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.8 | 5.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.7 | 3.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.7 | 8.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.6 | 1.9 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.6 | 1.2 | GO:0098590 | plasma membrane region(GO:0098590) |
| 0.5 | 5.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.5 | 15.2 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.4 | 2.5 | GO:0031673 | H zone(GO:0031673) |
| 0.4 | 2.0 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.4 | 1.2 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.4 | 6.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.3 | 7.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.3 | 3.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 2.7 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 7.0 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.3 | 2.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 3.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.3 | 1.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.3 | 4.4 | GO:0032039 | integrator complex(GO:0032039) |
| 0.3 | 1.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.3 | 1.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.3 | 3.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 1.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.2 | 6.3 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 3.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 2.0 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 25.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.2 | 5.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.2 | 2.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.2 | 2.8 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 5.2 | GO:0000786 | nucleosome(GO:0000786) |
| 0.2 | 0.6 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.2 | 2.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.2 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 1.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 2.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.2 | 0.5 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.2 | 2.7 | GO:0045179 | apical cortex(GO:0045179) |
| 0.2 | 3.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.2 | 19.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.2 | 1.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 2.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 2.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 1.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 1.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 1.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 0.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.1 | 9.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 17.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 1.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 2.3 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 1.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 2.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 0.4 | GO:1990075 | kinesin II complex(GO:0016939) periciliary membrane compartment(GO:1990075) |
| 0.1 | 3.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 0.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.1 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.1 | 2.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 12.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 2.0 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 2.3 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 3.1 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 1.6 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 2.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 6.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 2.2 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 1.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 2.6 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 2.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 16.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.1 | 1.0 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 0.7 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 3.2 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 3.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 3.0 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 6.3 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 1.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 4.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 6.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 2.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 5.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 28.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.1 | 6.2 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 1.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 1.7 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.1 | 2.9 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 1.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.0 | 8.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 1.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 1.2 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 2.3 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.0 | 6.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 1.6 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 4.8 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 2.3 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 1.4 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 0.0 | 1.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.0 | 1.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 5.8 | GO:0031674 | I band(GO:0031674) |
| 0.0 | 3.7 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 3.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 5.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 2.7 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.0 | 3.7 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 3.5 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 25.6 | GO:0016604 | nuclear body(GO:0016604) |
| 0.0 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.0 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.0 | 0.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.0 | 0.4 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.0 | 0.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 4.9 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.0 | 0.4 | GO:0045202 | synapse(GO:0045202) |
| 0.0 | 0.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.4 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
| 0.0 | 0.9 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 1.0 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.0 | 1.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 2.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.1 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 11.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 2.9 | 14.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 2.4 | 16.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 2.3 | 23.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 1.3 | 5.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 1.2 | 8.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.1 | 25.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 1.1 | 16.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 1.0 | 14.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 1.0 | 3.0 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.9 | 4.6 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.9 | 8.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.9 | 14.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.8 | 2.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.8 | 3.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.7 | 2.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.7 | 2.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.7 | 4.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.7 | 12.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.7 | 3.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.7 | 2.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.6 | 1.9 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.6 | 4.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.6 | 7.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.6 | 6.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.6 | 5.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.5 | 11.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.5 | 4.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.5 | 2.1 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.5 | 8.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.5 | 2.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.5 | 2.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.5 | 3.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.5 | 6.7 | GO:0047035 | alcohol dehydrogenase (NAD) activity(GO:0004022) testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.4 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 15.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.4 | 1.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.4 | 5.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.4 | 8.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.4 | 7.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.4 | 6.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.4 | 1.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.4 | 1.4 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.4 | 5.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.3 | 2.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.3 | 4.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.3 | 3.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.3 | 1.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.3 | 9.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 1.3 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.3 | 2.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.3 | 7.2 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.3 | 1.0 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.3 | 1.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.3 | 1.0 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.3 | 4.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.3 | 1.6 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 3.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 1.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.3 | 2.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.3 | 15.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.3 | 1.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 1.1 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.3 | 2.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 19.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.3 | 2.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.2 | 0.7 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 3.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 5.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.2 | 11.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 12.8 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.2 | 4.7 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.2 | 1.1 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.2 | 2.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 1.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.2 | 2.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 1.2 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.2 | 1.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 2.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 2.6 | GO:0008526 | phosphatidylcholine transporter activity(GO:0008525) phosphatidylinositol transporter activity(GO:0008526) |
| 0.2 | 2.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 2.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 1.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.2 | 2.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.2 | 3.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 1.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.2 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 2.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 1.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.2 | 1.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 5.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.2 | 1.3 | GO:0042835 | BRE binding(GO:0042835) |
| 0.2 | 3.3 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 0.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.2 | 15.5 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.7 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 0.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.1 | 0.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 2.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.8 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 1.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 2.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 39.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 11.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.4 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.1 | 1.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.4 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.1 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 1.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 5.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 2.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 3.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 5.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 2.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 4.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 3.2 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.1 | 5.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.1 | 2.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 3.6 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 1.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 4.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.1 | 2.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.1 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 21.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 2.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 4.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 4.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 1.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 1.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.1 | 1.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 2.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 3.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 3.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 1.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.1 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 9.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 8.2 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 2.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 4.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 2.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 1.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 2.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 4.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.1 | 1.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 1.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.9 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.1 | 3.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.2 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.1 | 1.6 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 2.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 3.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 1.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 1.8 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 1.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.8 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
| 0.1 | 1.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 1.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 8.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 4.8 | GO:0008134 | transcription factor binding(GO:0008134) |
| 0.1 | 1.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 2.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 3.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.0 | 0.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.0 | 6.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 1.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.0 | 0.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.0 | 1.2 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 2.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.0 | 2.0 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 2.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.0 | 1.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.0 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 9.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 1.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.0 | 12.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 7.3 | GO:0005506 | iron ion binding(GO:0005506) |
| 0.0 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.0 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 1.2 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 3.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 1.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.0 | 6.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.0 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.0 | 1.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 3.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
| 0.0 | 2.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.7 | GO:0043236 | laminin binding(GO:0043236) |
| 0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.0 | 0.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.0 | 0.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.0 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.0 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.0 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.1 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 2.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.6 | 15.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.5 | 16.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.5 | 12.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.4 | 11.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 30.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.3 | 3.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 16.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 14.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.2 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.2 | 52.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.2 | 6.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 11.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.2 | 9.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.2 | 3.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 5.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 2.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 9.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 5.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 9.8 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 1.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 3.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 10.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 6.0 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 8.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 2.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 5.2 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 2.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 1.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 10.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 1.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 4.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 3.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 5.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 7.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 4.4 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 4.6 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 1.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 3.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.9 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 1.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 3.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 8.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 0.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 1.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 16.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.7 | 15.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.6 | 31.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.4 | 34.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.3 | 10.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 2.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 3.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 9.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.3 | 12.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.3 | 6.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 4.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 2.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 4.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.2 | 12.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 19.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 3.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.2 | 4.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 2.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 14.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.2 | 2.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.2 | 3.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 5.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 2.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 7.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 2.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 5.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 3.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 3.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 4.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 3.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 6.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 3.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 2.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 2.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 2.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 1.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 2.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 2.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 12.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 1.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 2.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 2.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.0 | 0.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 5.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 2.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 4.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 1.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 1.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.8 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
| 0.0 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 1.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 3.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 3.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 1.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 1.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 3.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.0 | 0.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 2.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 3.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.0 | 2.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |